Search

everythinglearnresearchcommunity

for

Search:↓

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

TrichoScan is reliable for counting and measuring hair density but may not accurately assess hair types in women with hair loss.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Alopecia areata can regrow hair in a pattern similar to androgenetic alopecia.

Amla fruit syrup improved hair growth and satisfaction in women with hair loss without significant side effects.

Finasteride effectively treats hair loss in transgender men with few side effects.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

The research found that certain genes are linked to male pattern baldness, but these same genes do not affect female pattern hair loss.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Two new signs, 'signet ring vessels' and 'hidden hairs,' help tell apart scalp psoriasis and seborrheic dermatitis.

Trichoscopy effectively diagnoses and assesses the severity of androgenetic alopecia.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Aromatase inhibitors cause male pattern hair loss in women.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.